Quantcast

Latest IMS Health Stories

2014-04-15 16:26:50

DUBLIN, April 15, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9b46rc/healthcare ) has announced the addition of the "Healthcare Analytics/Medical Analytics Market by Application, Type, End-user, Delivery Mode - Trends & Global Forecasts to 2020" [http://www.researchandmarkets.com/research/9b46rc/healthcare ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Healthcare analytics...

2014-04-15 12:30:09

PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that it and its partner Famy Care Ltd. have entered into a settlement and license agreement with Warner Chilcott Company, LLC, settling the parties' litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This...

2014-04-11 08:24:31

PITTSBURGH, April 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and Mylan settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Frovatriptan Succinate Tablets, 2.5 mg. This product is the generic version of FROVA(®), which is used to treat acute...

2014-03-27 12:30:57

Specialty Ophthalmic Company in Mexico; Enters the Latin American Market MUMBAI, India and BALTIMORE, March 27, 2014 /PRNewswire/ -- Pharma Major Lupin Limited announced today the acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V. (Grin), Mexico, subject to certain closing conditions. The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American pharmaceuticals market. Mexico is one of the fastest growing pharmaceutical markets in the...

2014-03-21 12:24:25

MUMBAI, India and BALTIMORE, March 21, 2014 /PRNewswire/ -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths having received final approval from the United States Food and Drug Administration (FDA) yesterday. Lupin's Niacin Extended-Release Tablets USP, 500 mg, 750 mg, 1000 mg strengths are the AB-rated generic...

2014-02-25 00:21:15

BARCELONA, Spain, February 25, 2014 /PRNewswire/ -- For the second year, Veeva Systems has been ranked by life sciences leaders as one of the top preferred software providers to the industry, based on the Leading Indicators in Life Science IT Spending Survey[1] released by IDC Health Insights. The 2014 report [http://eu.veeva.com/resources/perspective-idc-health-insights-top-preferred-life-science-technology-vendors-for-2014 ] shows Veeva was the only software provider to...

2014-02-20 08:28:49

Cognizant Also Named a Leader in Strategic Consulting in Manufacturing and Supply Chain, and Sales and Marketing TEANECK, N.J., Feb. 20, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been positioned as a "Leader" in the IDC Health Insights "IDC MarketScape" worldwide IT and BPO vendor assessments* across the entire life sciences value chain: Research and Development, Manufacturing and Supply Chain, and Sales and Marketing. Cognizant was also named a "Leader" in...

2014-02-18 08:31:12

MUMBAI, India and BALTIMORE, February 18, 2014 /PRNewswire/ -- Pharma major Lupin, today announced the appointment of Dr. Maurice Chagnaud as its President, Europe and Head of Inhalation Strategy. He will be based at Schaffhausen, Switzerland. Dr. Chagnaud has over 20 years of experience in Pharmaceutical business in Europe having worked with Teva and Merck Generics. He joins Lupin from Israeli drug major, Teva, where he was the Senior Vice President, Central & Eastern...

2014-02-13 23:21:06

Healthcare Analytics Market research report covers the global market by type, application, delivery mode, component, end user, and geography. http://www.marketsandmarkets.com/Market-Reports/healthcare-data-analytics-market-905.html (PRWEB) February 13, 2014 The "Healthcare Analytics/Medical Analytics Market by Application (Clinical, Financial, & Operational), Type (Predictive, & Prescriptive), End-user (Payer, Provider, HIE, ACO), Delivery Mode (On-premise, Web, & Cloud)...

2014-01-23 16:24:38

PITTSBURGH, Jan. 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin(®), which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.(1) The company received final approval from the U.S. Food and Drug Administration (FDA) for its...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related